Aerovate Therapeutics (AVTE) Q3 2023 Earnings

13NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.71
-0.47
-0.24
0

Details

Expected EPS
-0.69
Actual EPS
-0.71
Surprise EPS
-0.02
Surprise Percent
+2.9%

Description

Aerovate Therapeutics (AVTE) has reported earnings of -0.71 per share for Q3 2023.

0 Comments

Share your thoughts